Press Resease

In-Vitro Diagnostics (IVD) Market by Product (Instruments, Reagents, and Services), by Technology (Immunology, Hematology, Clinical Chemistry, Molecular Diagnostics, Coagulation, Microbiology, and Others), by Application (Infectious Disease, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, and Others), and by End-Use (Hospital, Laboratory, Home Care, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Published Date: 02-May-2019 Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2875 Status : Published

Global in-vitro diagnostics (IVD) market expected to reach approximately USD 70,730 million by 2025, at a CAGR of around 5.01% between 2019 and 2025. In-vitro diagnostics (IVD) is used to identify various types of diseases and infections. In-vitro diagnostics products include reagents, instruments, etc. that are used for the infection analysis.

Description

The report covers a forecast and an analysis for the in-vitro diagnostics (IVD) market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the in-vitro diagnostics (IVD) market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities and threats to the in-vitro (IVD) market on a global level.

To understand the competitive landscape in the market, an analysis of Porter's Five Forces Model for the in-vitro diagnostics (IVD) market has also been included. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

Global In Vitro Diagnostics (IVD) Market

The study provides a decisive view of the in-vitro diagnostics (IVD) market based on product, technology, application, end-use, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa with its further classification into major countries including the U.S., Germany, France, UK, China, Japan, India, and Brazil.

Some key players of the global in-vitro diagnostics (IVD) market are Alere, bioMerieux SA, Becton, Dickinson, and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Qiagen, Hologic, Inc. (Gen-Probe), Abbott, Danaher, Sysmex Corporation, and Cepheid.

This report segments the global in-vitro diagnostics (IVD) market into:

Global In-Vitro Diagnostics (IVD) Market: By Product

  • Instruments
  • Reagents
  • Services

Global In-Vitro Diagnostics (IVD) Market: By Technology

  • Immunology
  • Hematology
  • Clinical Chemistry
  • Molecular Diagnostics
  • Coagulation
  • Microbiology
  • Others

Global In-Vitro Diagnostics (IVD) Market: By Application

  • Infectious Disease
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases
  • Drug Testing
  • Others

Global In-Vitro Diagnostics (IVD) Market: By End-Use

  • Hospital
  • Laboratory
  • Home Care
  • Others

Global In-Vitro Diagnostics (IVD) Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global In-Vitro Diagnostics (IVD) Market, 2015-2025 (USD Million)
    • 2.2. Global In-Vitro Diagnostics (IVD) Market: Snapshot
  •  
  • Chapter 3. In-Vitro Diagnostics (IVD) Market - Industry Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Global In-Vitro Diagnostics (IVD) Market Drivers: Impact Analysis
      • 3.2.2. Growing Geriatric Population
      • 3.2.3. The Increasing Prevalence of Chronic Diseases
      • 3.2.4. Introduction of Technologically Advanced Diagnostics
      • 3.2.5. Increasing Demand for Point-of-care Diagnostics
    • 3.3. Market Restraints
      • 3.3.1. Global In-Vitro Diagnostics (IVD) Market Restraints: Impact Analysis
      • 3.3.2. Stringent Regulatory Policies
      • 3.3.3. The High Cost of Devices
    • 3.4. Opportunities
      • 3.4.1. Penetration and growth prospect mapping
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market Attractiveness Analysis, By Product
      • 3.6.2. Market Attractiveness Analysis, By Technology
      • 3.6.3. Market Attractiveness Analysis, By Application
      • 3.6.4. Market Attractiveness Analysis, By End-Use
      • 3.6.5. Market Attractiveness Analysis, By Region
  •  
  • Chapter 4. Global In-Vitro Diagnostics (IVD) Market - Competitive Landscape
    • 4.1. Company Market Share, 2018(Subject To Data Availability)
      • 4.1.1. Global In-Vitro Diagnostics (IVD) Market: Company Market Share, 2018
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. Research and Development, Product and Regional Expansion
    • 4.3. Product Portfolio
  •  
  • Chapter 5. Global In-Vitro Diagnostics (IVD) Market - Product Analysis
    • 5.1. Global In-Vitro Diagnostics (IVD) Market: Product Overview
      • 5.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, by Product, 2018 and 2025
    • 5.2. Instruments
      • 5.2.1. Global In-Vitro Diagnostics (IVD) Market for Instruments, 2015-2025 (USD Million)
    • 5.3. Reagents
      • 5.3.1. Global In-Vitro Diagnostics (IVD) Market for Reagents, 2015-2025 (USD Million)
    • 5.4. Services
      • 5.4.1. Global In-Vitro Diagnostics (IVD) Market for Services, 2015-2025 (USD Million)
  •  
  • Chapter 6. Global In-Vitro Diagnostics (IVD) Market - Technology Analysis
    • 6.1. Global In-Vitro Diagnostics (IVD) Market: Technology Overview
      • 6.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, by Technology, 2018 and 2025
    • 6.2. Immunology
      • 6.2.1. Global In-Vitro Diagnostics (IVD) Market for Immunology, 2015-2025 (USD Million)
    • 6.3. Hematology
      • 6.3.1. Global In-Vitro Diagnostics (IVD) Market for Hematology, 2015-2025 (USD Million)
    • 6.4. Clinical chemistry
      • 6.4.1. Global In-Vitro Diagnostics (IVD) Market for Clinical chemistry, 2015-2025 (USD Million)
    • 6.5. Molecular Diagnostics
      • 6.5.1. Global In-Vitro Diagnostics (IVD) Market for Molecular Diagnostics, 2015-2025 (USD Million)
    • 6.6. Coagulation
      • 6.6.1. Global In-Vitro Diagnostics (IVD) Market for Coagulation, 2015-2025 (USD Million)
    • 6.7. Microbiology
      • 6.7.1. Global In-Vitro Diagnostics (IVD) Market for Microbiology, 2015-2025 (USD Million)
    • 6.8. Others
      • 6.8.1. Global In-Vitro Diagnostics (IVD) Market for Others, 2015-2025 (USD Million)
  •  
  • Chapter 7. Global In-Vitro Diagnostics (IVD) Market - Application Analysis
    • 7.1. Global In-Vitro Diagnostics (IVD) Market: Application Overview
      • 7.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, by Application, 2018 and 2025
    • 7.2. Infectious Disease
      • 7.2.1. Global In-Vitro Diagnostics (IVD) Market for Infectious Disease, 2015-2025 (USD Million)
    • 7.3. Diabetes
      • 7.3.1. Global In-Vitro Diagnostics (IVD) Market for Diabetes, 2015-2025 (USD Million)
    • 7.4. Oncology
      • 7.4.1. Global In-Vitro Diagnostics (IVD) Market for Oncology, 2015-2025 (USD Million)
    • 7.5. Cardiology
      • 7.5.1. Global In-Vitro Diagnostics (IVD) Market for Cardiology, 2015-2025 (USD Million)
    • 7.6. Nephrology
      • 7.6.1. Global In-Vitro Diagnostics (IVD) Market for Nephrology, 2015-2025 (USD Million)
    • 7.7. Autoimmune diseases
      • 7.7.1. Global In-Vitro Diagnostics (IVD) Market for Autoimmune diseases, 2015-2025 (USD Million)
    • 7.8. Drug testing
      • 7.8.1. Global In-Vitro Diagnostics (IVD) Market for Drug testing, 2015-2025 (USD Million)
    • 7.9. Others
      • 7.9.1. Global In-Vitro Diagnostics (IVD) Market for Others, 2015-2025 (USD Million)
  •  
  • Chapter 8. Global In-Vitro Diagnostics (IVD) Market - End-Use Analysis
    • 8.1. Global In-Vitro Diagnostics (IVD) Market: End-Use Overview
      • 8.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, by End-Use, 2018 and 2025
    • 8.2. Hospital
      • 8.2.1. Global In-Vitro Diagnostics (IVD) Market for Hospital, 2015-2025 (USD Million)
    • 8.3. Laboratory
      • 8.3.1. Global In-Vitro Diagnostics (IVD) Market for Laboratory, 2015-2025 (USD Million)
    • 8.4. Home care
      • 8.4.1. Global In-Vitro Diagnostics (IVD) Market for Home Care, 2015-2025 (USD Million)
    • 8.5. Others
      • 8.5.1. Global In-Vitro Diagnostics (IVD) Market for Others, 2015-2025 (USD Million)
  •  
  • Chapter 9. Global In-Vitro Diagnostics (IVD) Market - Regional Analysis
    • 9.1. Global In-Vitro Diagnostics (IVD) Market: Regional Overview
      • 9.1.1. Global In-Vitro Diagnostics (IVD) Market Revenue Share, by Region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America In-Vitro Diagnostics (IVD) Market Revenue, by Product, 2015-2025 (USD Million)
      • 9.2.2. North America In-Vitro Diagnostics (IVD) Market Revenue, by Technology, 2015-2025 (USD Million)
      • 9.2.3. North America In-Vitro Diagnostics (IVD) Market Revenue, by Application, 2015-2025 (USD Million)
      • 9.2.4. North America In-Vitro Diagnostics (IVD) Market Revenue, by End-Use, 2015-2025 (USD Million)
      • 9.2.5. The U.S.
        • 9.2.5.1. The U.S. In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.2.5.2. The U.S. In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.2.5.3. The U.S. In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.2.5.4. The U.S. In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.2.6. Rest of North America
        • 9.2.6.1. Rest of North America In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.2.6.2. Rest of North America In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.2.6.3. Rest of North America In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.2.6.4. Rest of North America In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
      • 9.3.2. Europe In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
      • 9.3.3. Europe In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
      • 9.3.4. Europe In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.3.5. UK
        • 9.3.5.1. UK In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.3.5.2. UK In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.3.5.3. UK In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.3.5.4. UK In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.3.6. France
        • 9.3.6.1. France In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.3.6.2. France In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.3.6.3. France In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.3.6.4. France In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.3.7. Germany
        • 9.3.7.1. Germany In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.3.7.2. Germany In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.3.7.3. Germany In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.3.7.4. Germany In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.3.8. Rest of Europe
        • 9.3.8.1. Rest of Europe In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.3.8.2. Rest of Europe In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.3.8.3. Rest of Europe In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.3.8.4. Rest of Europe In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
      • 9.4.2. Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
      • 9.4.3. Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
      • 9.4.4. Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.4.5. China
        • 9.4.5.1. China In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.4.5.2. China In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.4.5.3. China In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.4.5.4. China In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.4.6. Japan
        • 9.4.6.1. Japan In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.4.6.2. Japan In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.4.6.3. Japan In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.4.6.4. Japan In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.4.7. India
        • 9.4.7.1. India In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.4.7.2. India In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.4.7.3. India In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.4.7.4. India In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.4.8. Rest of Asia Pacific
        • 9.4.8.1. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.4.8.2. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.4.8.3. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.4.8.4. Rest of Asia Pacific In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
      • 9.5.2. Latin America In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
      • 9.5.3. Latin America In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
      • 9.5.4. Latin America In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.5.5. Brazil
        • 9.5.5.1. Brazil In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.5.5.2. Brazil In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.5.5.3. Brazil In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.5.5.4. Brazil In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
      • 9.5.6. Rest of Latin America
        • 9.5.6.1. Rest of Latin America In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
        • 9.5.6.2. Rest of Latin America In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
        • 9.5.6.3. Rest of Latin America In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
        • 9.5.6.4. Rest of Latin America In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
    • 9.6. The Middle East and Africa
      • 9.6.1. The Middle East and Africa In-Vitro Diagnostics (IVD) Market Revenue, By Product, 2015-2025 (USD Million)
      • 9.6.2. The Middle East and Africa In-Vitro Diagnostics (IVD) Market Revenue, By Technology, 2015-2025 (USD Million)
      • 9.6.3. The Middle East and Africa In-Vitro Diagnostics (IVD) Market Revenue, By Application, 2015-2025 (USD Million)
      • 9.6.4. The Middle East and Africa In-Vitro Diagnostics (IVD) Market Revenue, By End-Use, 2015-2025 (USD Million)
  •  
  • Chapter 10. Company Profile
    • 10.1. BioMerieux SA
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. Hoffmann-La Roche Ltd.
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business strategy
      • 10.2.5. Recent developments
    • 10.3. Becton, Dickinson, and Company
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business strategy
      • 10.3.5. Recent developments
    • 10.4. Hologic, Inc. (Gen-Probe)
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business strategy
      • 10.4.5. Recent developments
    • 10.5. Siemens Healthineers
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business strategy
      • 10.5.5. Recent developments
    • 10.6. Abbott
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business strategy
      • 10.6.5. Recent developments
    • 10.7. Danaher
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 10.7.3. Product Portfolio
      • 10.7.4. Business strategy
      • 10.7.5. Recent developments
    • 10.8. Sysmex Corporation
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business strategy
      • 10.8.5. Recent developments
    • 10.9. Qiagen
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business strategy
      • 10.9.5. Recent developments
    • 10.10. Cepheid
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business strategy
      • 10.10.5. Recent developments

Methodology

Free Analysis

In-vitro diagnostics (IVD) is used to identify various types of diseases and infections. In-vitro diagnostics products include reagents, instruments, etc. that are used for the infection analysis. The demand for in-vitro diagnostics (IVD) is on the rise due to the growing occurrences of chronic diseases across the world. As per the Centre for Disease Control and Prevention, around 117 million people suffered from chronic diseases in the U.S. in 2012. Thus, to analyze chronic diseases, sexually transmitted diseases, infectious diseases, oncology, and genetic testing, the number of analytical tests is rising globally. Other factors likely to push the in-vitro diagnostics (IVD) market growth include rising geriatric population, growing incidences of long-lasting lifestyle-related diseases, an increasing number of infectious diseases, escalating alertness of personalized medicine, and the augmenting acceptance of point-of-care analysis. Though, stringent regulatory outlines and insufficient compensation may restrict the global in-vitro diagnostics (IVD) market growth to a certain extent.

The global in-vitro diagnostics (IVD) market is categorized based on the product, technology, application, and end-use. Based on product, the global in-vitro diagnostics (IVD) market is divided into instruments, reagents, and services. Based on technology, the market includes immunology, coagulation, clinical chemistry, microbiology, hematology, molecular diagnostics, and others. By application, the market includes cardiology, infectious disease, autoimmune diseases, diabetes, drug testing, nephrology, oncology, and others. The infectious disease segment is projected to hold the largest market share in the upcoming years, owing to the high incidences of tuberculosis, pneumonia, and HIV/AIDS. The oncology segment is likely to witness the fastest CAGR in the years ahead, owing to the growing demand for POC diagnostics and self-care devices for long-lasting diseases management. Based on end-user, the market includes hospital, laboratory, home care, and others. Hospitals are estimated to dominate globally in the forthcoming years owing to the huge demand for hospitalization of patients.

Global In Vitro Diagnostics (IVD) Market

By region, North America will be the fastest growing region in the global in-vitro diagnostics (IVD) market in the future. Promising government rules, huge healthcare spending, and the presence of renowned key players operating in the market are some significant factors for this regional market’s development. Asia Pacific is predicted to witness the fastest progress rate over the estimated time period, owing to the huge unmet clinical requirements and improving healthcare structure across the region.

Some key players of the global in-vitro diagnostics (IVD) market are Alere, bioMerieux SA, Becton, Dickinson, and Company, F. Hoffmann-La Roche Ltd., Siemens Healthineers, Qiagen, Hologic, Inc. (Gen-Probe), Abbott, Danaher, Sysmex Corporation, and Cepheid.

}
Office Address

Corporate Office
Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office
3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #
US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com